Eye Infections, Bacterial
5
Pipeline Programs
1
Companies
5
Clinical Trials
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
5
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
1 companies ranked by most advanced pipeline stage
Thea PharmaMA - Waltham
5 programs5
AzithromycinPhase 11 trial
AzithromycinPhase 11 trial
AzithromycinPhase 11 trial
AzithromycinPhase 11 trial
AzithromycinPhase 11 trial
Active Trials
+2 more trials
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
Thea PharmaAzithromycin
Thea PharmaAzithromycin
Thea PharmaAzithromycin
Thea PharmaAzithromycin
Thea PharmaAzithromycin
Clinical Trials (5)
Azithromycin Level in Tears and in Conjunctiva in 36 Healthy Volunteers
Start: Feb 2003Est. completion: Mar 2003
Phase 1Completed
Study of the Ocular Safety After Repeated Instillations of T1225 1% or 1.5% Eye Drops in Healthy Volunteers
Start: Oct 2002Est. completion: Oct 2002
Phase 1Completed
Ocular Pharmacokinetics After a Single Drop Instillation of T1225 0.5, 1, 1.5% in 91 Healthy Volunteers
Start: May 2002Est. completion: Jun 2002
Phase 1Completed
Ocular Tolerance, Safety and Ocular Pharmacokinetics After 1 Drop of T1225 0.5, 1.0, 1.5% in 48 Healthy Volunteers
Start: Mar 2002Est. completion: Apr 2002
Phase 1Completed
Safety and Ocular Pharmacokinetics After 1 Drop of T1225 0.5, 1 and 1.5% in 48 Healthy Volunteers
Start: Feb 2002Est. completion: Mar 2002
Phase 1Completed
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
1 companies competing in this space